• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏膜下浸润性结直肠癌淋巴结转移的新预测因子。

Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma.

机构信息

Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea.

Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea.

出版信息

World J Gastroenterol. 2017 Aug 28;23(32):5936-5944. doi: 10.3748/wjg.v23.i32.5936.

DOI:10.3748/wjg.v23.i32.5936
PMID:28932085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5583578/
Abstract

AIM

To evaluate a novel grading system to predict lymph node metastasis (LNM) in patients with submucosal invasive colorectal carcinoma (SICRC).

METHODS

We analyzed the associations between LNM and various clinicopathological features in 252 patients with SICRC who had undergone radical surgery at the Seoul Saint Mary's hospital between 2000 and 2015.

RESULTS

LNM was observed in 31 patients (12.3%). The depth and width of the submucosal invasion, lymphatic invasion, tumor budding, and the presence of poorly differentiated clusters (PDCs) were significantly associated with the incidence of LNM. Using multivariate analysis, the receiver operating characteristic curvewas calculated and the area under curve (AUC) was used to compare the ability of the different parameters to identify the risk of LNM. The most powerful clinicopathological parameter for predicting LNM was lymphatic invasion (difference AUC = 0.204), followed by the presence or absence of tumor budding (difference AUC = 0.190), presence of PDCs (difference AUC = 0.172) and tumor budding graded by the Ueno method (difference AUC = 0.128).

CONCLUSION

Our results indicate that the tumor budding and the depth multiplied by the width measurements of submucosal invasion can provide important information for patients with SICRC.

摘要

目的

评估一种新的分级系统,以预测黏膜下浸润性结直肠癌(SICRC)患者的淋巴结转移(LNM)。

方法

我们分析了 2000 年至 2015 年间在首尔圣玛丽医院接受根治性手术的 252 例 SICRC 患者的 LNM 与各种临床病理特征之间的关系。

结果

31 例(12.3%)发生 LNM。黏膜下浸润深度和宽度、淋巴管浸润、肿瘤芽生以及低分化簇(PDC)的存在与 LNM 的发生率显著相关。使用多变量分析,计算了受试者工作特征曲线,并使用曲线下面积(AUC)比较了不同参数识别 LNM 风险的能力。预测 LNM 的最有力的临床病理参数是淋巴管浸润(差异 AUC = 0.204),其次是肿瘤芽生的存在与否(差异 AUC = 0.190)、PDC 的存在(差异 AUC = 0.172)以及 Ueno 方法分级的肿瘤芽生(差异 AUC = 0.128)。

结论

我们的结果表明,肿瘤芽生和黏膜下浸润深度乘以宽度的测量值可为 SICRC 患者提供重要信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/4df34128931e/WJG-23-5936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/1eb036045b51/WJG-23-5936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/30fbd1286599/WJG-23-5936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/4df34128931e/WJG-23-5936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/1eb036045b51/WJG-23-5936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/30fbd1286599/WJG-23-5936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21af/5583578/4df34128931e/WJG-23-5936-g003.jpg

相似文献

1
Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma.黏膜下浸润性结直肠癌淋巴结转移的新预测因子。
World J Gastroenterol. 2017 Aug 28;23(32):5936-5944. doi: 10.3748/wjg.v23.i32.5936.
2
Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma.预测黏膜下浸润(T1)结直肠癌淋巴结转移的病理预后因素。
Mod Pathol. 2010 Aug;23(8):1068-72. doi: 10.1038/modpathol.2010.88. Epub 2010 May 14.
3
Predictive Factors for Lymph Node Metastasis in Submucosal Invasive Colorectal Carcinoma: A New Proposal of Depth of Invasion for Radical Surgery.黏膜下浸润性结直肠癌淋巴结转移的预测因素:根治性手术侵袭深度的新提议
World J Surg. 2018 Aug;42(8):2635-2641. doi: 10.1007/s00268-018-4482-4.
4
A clinical model for predicting lymph node metastasis in submucosal invasive (T1) colorectal cancer.一种预测黏膜下浸润性(T1)结直肠癌淋巴结转移的临床模型。
Int J Colorectal Dis. 2015 Jun;30(6):761-8. doi: 10.1007/s00384-015-2164-3. Epub 2015 Feb 21.
5
Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis.深度黏膜下浸润不是 T1 结直肠癌淋巴结转移的独立危险因素:一项荟萃分析。
Gastroenterology. 2022 Jul;163(1):174-189. doi: 10.1053/j.gastro.2022.04.010. Epub 2022 Apr 15.
6
Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer.肿瘤芽生可独立预测早期胃癌的淋巴结受累情况。
Int J Surg Pathol. 2015 Aug;23(5):349-58. doi: 10.1177/1066896915581200. Epub 2015 Apr 24.
7
Predictors for lymph node metastasis in T1 colorectal cancer.T1 结直肠癌淋巴结转移的预测因素。
Endoscopy. 2012 Jun;44(6):590-5. doi: 10.1055/s-0031-1291665. Epub 2012 May 25.
8
Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.早期浸润性结直肠癌淋巴结转移的新危险因素:多机构病理学回顾
J Gastroenterol. 2014 Sep;49(9):1314-23. doi: 10.1007/s00535-013-0881-3. Epub 2013 Sep 25.
9
Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.与息肉样生长相比,肿瘤芽生可预测黏膜下浸润性结直肠癌及非息肉样病变中的淋巴管侵犯和淋巴结转移。
Scand J Gastroenterol. 2009;44(5):605-14. doi: 10.1080/00365520902718911.
10
Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.T1期结直肠癌黏膜下浸润分级标准在预后评估中的临床应用价值
J Gastroenterol. 2003;38(1):37-44. doi: 10.1007/s005350300004.

引用本文的文献

1
Tumor Budding as a Risk Factor for Lymph Node Metastasis and Local Recurrence in pT1 Colorectal Cancer: A Systematic Review and Meta-Analysis.肿瘤芽生作为pT1期结直肠癌淋巴结转移和局部复发的危险因素:一项系统评价和荟萃分析
Gastro Hep Adv. 2025 May 27;4(9):100713. doi: 10.1016/j.gastha.2025.100713. eCollection 2025.
2
Histological Risk Factors for Lymph Node Metastasis in pT1 Colorectal Cancer: Does Submucosal Invasion Depth Really Matter?pT1 结直肠癌的淋巴结转移的组织学危险因素:黏膜下浸润深度真的重要吗?
Curr Med Sci. 2024 Oct;44(5):1026-1035. doi: 10.1007/s11596-024-2926-7. Epub 2024 Oct 11.
3
How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma?

本文引用的文献

1
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2014年结直肠癌治疗指南。
Int J Clin Oncol. 2015 Apr;20(2):207-39. doi: 10.1007/s10147-015-0801-z. Epub 2015 Mar 18.
2
Area of submucosal invasion and width of invasion predicts lymph node metastasis in pT1 colorectal cancers.黏膜下浸润面积和浸润宽度可预测pT1期结直肠癌的淋巴结转移。
Dis Colon Rectum. 2015 Apr;58(4):393-400. doi: 10.1097/DCR.0000000000000315.
3
A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.
在T1期伴有癌的息肉中实施后,我们能期望监测策略有多安全?
World J Gastrointest Endosc. 2024 Sep 16;16(9):502-508. doi: 10.4253/wjge.v16.i9.502.
4
A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer.T1和T2期结直肠癌淋巴结转移危险因素、分层及预后的回顾性多中心研究
J Clin Med. 2023 Dec 18;12(24):7744. doi: 10.3390/jcm12247744.
5
Weighing the benefits of lymphadenectomy in early-stage colorectal cancer.权衡早期结直肠癌淋巴结清扫术的益处。
Ann Surg Treat Res. 2023 Nov;105(5):245-251. doi: 10.4174/astr.2023.105.5.245. Epub 2023 Oct 31.
6
Additional staining for lymphovascular invasion is associated with increased estimation of lymph node metastasis in patients with T1 colorectal cancer: Systematic review and meta-analysis.额外的淋巴管侵犯染色与 T1 结直肠癌患者淋巴结转移估计增加相关:系统评价和荟萃分析。
Dig Endosc. 2024 May;36(5):533-545. doi: 10.1111/den.14691. Epub 2023 Oct 25.
7
Lymph node metastasis in T1-2 colorectal cancer: a population-based study.T1-2 期结直肠癌的淋巴结转移:一项基于人群的研究。
Int J Colorectal Dis. 2023 Apr 13;38(1):94. doi: 10.1007/s00384-023-04386-w.
8
A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer.关于T1期结直肠癌内镜切除术后淋巴结转移风险分级的建议。
Int J Colorectal Dis. 2023 Jan 26;38(1):25. doi: 10.1007/s00384-023-04319-7.
9
Multidisciplinary Treatment Strategy for Early Colon Cancer: A Review-An English Version.早期结肠癌的多学科治疗策略:综述——英文版
J Anus Rectum Colon. 2022 Oct 27;6(4):203-212. doi: 10.23922/jarc.2022-046. eCollection 2022.
10
Risk Factors for Predicting Lymph Node Metastasis in Submucosal Colorectal Cancer.预测结直肠黏膜下癌淋巴结转移的危险因素
J Anus Rectum Colon. 2022 Jul 28;6(3):181-189. doi: 10.23922/jarc.2022-002. eCollection 2022.
基于黏膜下浸润深度和出芽/萌芽情况的三级分类系统可改善T1期结直肠癌的治疗策略:一项回顾性多中心研究
Mod Pathol. 2015 Jun;28(6):872-9. doi: 10.1038/modpathol.2015.36. Epub 2015 Feb 27.
4
Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review.早期浸润性结直肠癌淋巴结转移的新危险因素:多机构病理学回顾
J Gastroenterol. 2014 Sep;49(9):1314-23. doi: 10.1007/s00535-013-0881-3. Epub 2013 Sep 25.
5
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.ESMO 结肠癌和直肠癌患者管理共识指南。 个体化临床决策方法。
Ann Oncol. 2012 Oct;23(10):2479-2516. doi: 10.1093/annonc/mds236.
6
Tumour budding: a promising parameter in colorectal cancer.肿瘤芽殖:结直肠癌有前途的参数。
Br J Cancer. 2012 May 22;106(11):1713-7. doi: 10.1038/bjc.2012.127. Epub 2012 Apr 24.
7
Are we achieving the benchmark of retrieving 12 lymph nodes in colorectal carcinoma specimens? Experience from a tertiary referral center in India and review of literature.我们是否达到了结直肠癌标本中获取12个淋巴结的基准?来自印度一家三级转诊中心的经验及文献综述。
Indian J Pathol Microbiol. 2012 Jan-Mar;55(1):38-42. doi: 10.4103/0377-4929.94853.
8
New criteria for histologic grading of colorectal cancer.结直肠癌组织学分级的新标准。
Am J Surg Pathol. 2012 Feb;36(2):193-201. doi: 10.1097/PAS.0b013e318235edee.
9
Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection.T1 结直肠癌的治疗,特别参考内镜下可切除的标准。
J Gastroenterol Hepatol. 2012 Jun;27(6):1057-62. doi: 10.1111/j.1440-1746.2011.07041.x.
10
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.日本结直肠癌症学会(JSCCR)2010 年结直肠癌治疗指南。
Int J Clin Oncol. 2012 Feb;17(1):1-29. doi: 10.1007/s10147-011-0315-2. Epub 2011 Oct 15.